Cian Healthcare Limited (BOM:542678)
India · Delayed Price · Currency is INR 9.55
+0.45 (4.95%)
At close: Jul 14, 2026
Cian Healthcare Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 13, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 239 | 86 | 517 | 700 | 476 | 263 | |
Market Cap Growth | 143.66% | -83.31% | -26.18% | 46.98% | 81.19% | -25.00% |
Enterprise Value | 681 | 631 | 1,089 | 1,315 | 1,098 | 971 |
Last Close Price | 9.55 | 3.45 | 20.67 | 28.00 | 19.05 | 11.25 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 13, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
PE Ratio | - | - | 60.88 | 34.49 | - | 494.93 |
PS Ratio | 1.03 | 0.28 | 0.84 | 1.02 | 0.61 | 0.36 |
PB Ratio | 0.88 | 0.27 | 0.89 | 1.22 | 0.86 | 0.45 |
P/TBV Ratio | 0.88 | 0.27 | 0.89 | 1.22 | 0.86 | 0.45 |
P/FCF Ratio | 2.68 | 0.42 | 4.79 | 19.91 | - | 5.89 |
P/OCF Ratio | 2.66 | 0.42 | 4.39 | 14.46 | 5.55 | 4.43 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 13, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
EV/Sales Ratio | 2.93 | 2.05 | 1.76 | 1.92 | 1.41 | 1.31 |
EV/EBITDA Ratio | - | - | 9.67 | 10.06 | 24.08 | 7.96 |
EV/EBIT Ratio | - | - | 18.78 | 17.20 | 383.92 | 11.10 |
EV/FCF Ratio | 7.64 | 3.10 | 10.10 | 37.40 | - | 21.76 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 13, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Debt / Equity Ratio | 2.03 | 1.70 | 0.96 | 1.06 | 1.14 | 1.21 |
Debt / EBITDA Ratio | - | - | 4.94 | 4.65 | 13.82 | 5.80 |
Debt / FCF Ratio | 6.16 | 2.70 | 5.16 | 17.30 | - | 15.85 |
Net Debt / Equity Ratio | 1.64 | 1.15 | 0.93 | 1.03 | 1.11 | 1.17 |
Net Debt / EBITDA Ratio | -4.91 | -5.70 | 4.84 | 4.55 | 13.53 | 5.61 |
Net Debt / FCF Ratio | 4.96 | 1.83 | 5.05 | 16.92 | -7.06 | 15.33 |
Asset Turnover | 0.16 | 0.20 | 0.39 | 0.42 | 0.48 | 0.47 |
Inventory Turnover | 0.83 | 0.69 | 0.81 | 0.90 | 1.39 | 1.62 |
Quick Ratio | 0.28 | 0.35 | 0.40 | 0.50 | 0.50 | 0.46 |
Current Ratio | 0.62 | 0.62 | 1.09 | 1.14 | 1.14 | 1.10 |
Return on Equity (ROE) | -39.23% | -57.29% | 1.47% | 3.59% | -9.73% | 0.09% |
Return on Assets (ROA) | -5.55% | -4.30% | 2.25% | 2.93% | 0.11% | 3.48% |
Return on Invested Capital (ROIC) | -18.12% | -11.97% | 5.05% | 6.53% | 0.24% | 0.53% |
Return on Capital Employed (ROCE) | -28.80% | -26.30% | 6.10% | 8.00% | 0.30% | 8.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 13, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Earnings Yield | -54.66% | -301.24% | 1.64% | 2.90% | -11.62% | 0.20% |
FCF Yield | 37.36% | 235.94% | 20.88% | 5.02% | -18.36% | 16.98% |
Buyback Yield / Dilution | 0.04% | - | -0.00% | - | 5.85% | -13.65% |